Oncolytics Biotech (Oncolytics Biotech) PB Ratio : 3.93 (As of Apr. 26, 2024)

View and export this data going back to 2001. Start your Free Trial

What is Oncolytics Biotech PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-26), Oncolytics Biotech's share price is $1.085. Oncolytics Biotech's Book Value per Share for the quarter that ended in Dec. 2023 was $0.28. Hence, Oncolytics Biotech's PB Ratio of today is 3.93.

The historical rank and industry rank for Oncolytics Biotech's PB Ratio or its related term are showing as below:

ONCY' s PB Ratio Range Over the Past 10 Years
Min: 0 Med: 0 Max: 10.81
Current: 4.02

During the past 13 years, Oncolytics Biotech's highest PB Ratio was 10.81. The lowest was 0.00. And the median was 0.00.

ONCY's PB Ratio is ranked worse than
69.62% of 1310 companies
in the Biotechnology industry
Industry Median: 2.385 vs ONCY: 4.02

During the past 12 months, Oncolytics Biotech's average Book Value Per Share Growth Rate was -14.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -11.60% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Oncolytics Biotech was 24.30% per year. The lowest was -44.00% per year. And the median was -12.90% per year.

Back to Basics: PB Ratio

Oncolytics Biotech PB Ratio Historical Data

The historical data trend for Oncolytics Biotech's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncolytics Biotech PB Ratio Chart

Oncolytics Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

PB Ratio

Get a 7-Day Free Trial

5.68

2.71

5.13

4.89

Oncolytics Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
PB Ratio	Get a 7-Day Free Trial															5.13	4.08	10.20	7.47	4.89

Competitive Comparison of Oncolytics Biotech's PB Ratio

For the Biotechnology subindustry, Oncolytics Biotech's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncolytics Biotech's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncolytics Biotech's PB Ratio distribution charts can be found below:

* The bar in red indicates where Oncolytics Biotech's PB Ratio falls into.

Oncolytics Biotech PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Oncolytics Biotech's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Dec. 2023)
	=	1.085	/	0.276
	=	3.93

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Oncolytics Biotech (NAS:ONCY) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Oncolytics Biotech PB Ratio Related Terms

Thank you for viewing the detailed overview of Oncolytics Biotech's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncolytics Biotech (Oncolytics Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncolytics Biotech Inc (NAS:ONCY) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

ONC:Canada

Address

322 11th Avenue S.W, Suite 804, Calgary, AB, CAN, T2R 0C5

Website

https://www.oncolyticsbiotech.com

Oncolytics Biotech Inc is a development-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. Its clinical development plan has the approval of its products as quickly as possible and expands its products into commercially valuable new treatment areas as objectives. The primary focus is to advance programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies.